T 0792/00 (Varied binding proteins/DYAX) vom 02.07.2002
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2002:T079200.20020702
- Datum der Entscheidung
- 2. Juli 2002
- Aktenzeichen
- T 0792/00
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 89910702.3
- IPC-Klasse
- C12N 15/00
- Verfahrenssprache
- Englisch
- Verteilung
- An die Kammervorsitzenden und -mitglieder verteilt (B)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Generation and selection of recombinant varied binding proteins
- Name des Antragstellers
- Dyax Corp.
- Name des Einsprechenden
- Cambridge Antibody Technology Limited
Acambis Research Limited - Kammer
- 3.3.04
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 100(b) 1973European Patent Convention Art 83 1973European Patent Convention R 27(1)(e) 1973
- Schlagwörter
- Sufficiency of disclosure - main and auxiliary requests 1 to 4 (no)
- Orientierungssatz
- (1) For sufficiency of disclosure (Articles 100(b) and 83 EPC), the Board has to be satisfied firstly that the patent specification certainly puts the skilled person in possession of at least one way of putting the claimed invention into practice, and secondly that the skilled person can put the invention into practice over the whole scope of the claim. If the Board is not satisfied on the first point that one way exists, the second point need not be considered (Point 2).
(2) If for an invention which goes against prevailing technical opinion the patentee has failed to give even a single reproducible example, sufficiency of disclosure cannot be acknowledged. It would amount to undue burden for the cautious and conservative skilled person to have to do research of his own to establish whether the invention can be put into practice in some circumstances, not specifically described in the patent, when prevailing technical opinion suggests the outcome will be failure (Points 3 to 5).
(3) If the patent contains only an example with a hypothetical experimental protocol, if this example is to be relied on for showing sufficiency, then the burden of proof lies on the patentee to show that in practice this protocol works as stated. Evidence that a variation of the protocol works is unlikely to be enough (Points 9 to 11).
ORDER
For these Reasons it is decided that:
The appeal is dismissed.